Source: Medicines and Medical Devices Safety Authority (NZ) Revision Year: 2019 Publisher: Pfizer New Zealand Limited, P O Box 3998, Auckland, New Zealand, 1140, Toll Free Number: 0800 736 363
DBL Sodium Nitroprusside 50 mg/2 mL Concentrated Injection Vial.
Pharmaceutical Form |
---|
Solution for injection. DBL Sodium Nitroprusside concentrated injection is a clear solution, sodium nitroprusside is a reddish-brown powder which is soluble in water. In aqueous solution, it is photosensitive and must be protected from light. |
DBL Sodium Nitroprusside concentrated injection is a sterile solution containing the equivalent of 50 milligram of sodium nitroprusside dihydrate [sodium nitrosylpentacyanoferrate (III)] per 2 mL, in sterile water for injections.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Nitroprusside |
The principal pharmacological action of nitroprusside is relaxation of vascular smooth muscle and consequent dilation of peripheral arteries and veins. Other smooth muscle (e.g. uterus, duodenum) is not affected. Nitroprusside is more active on veins than on arteries. |
List of Excipients |
---|
Water for injection |
DBL Sodium Nitroprusside concentrated injection is a clear solution available in amber glass vials containing the equivalent of 50 mg sodium nitroprusside dihydrate in 2 mL solution..
Strength | Volume | Pack Size |
---|---|---|
50 milligram/2 mL | 2 mL | vial 1 |
Pfizer New Zealand Limited, P O Box 3998, Auckland, New Zealand, 1140, Toll Free Number: 0800 736 363
Date of first approval: 01 Nov 2012
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.